A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y<sub>12</sub> receptor in platelets.
Makkawi, Mohammed; Howells, David; Wright, Mark D; Jackson, Denise E.
; 161: 12-21, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29178985
Underlying mechanism and specific prevention of hemolysis-induced platelet activation.
Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Assessment of steady-state clopidogrel reactivity by using platelet reactivity units.
Antiplatelet drug resistance: Molecular insights and clinical implications.
The effects of clopidogrel and omeprazole on platelet function in normal dogs.
Effects of Concurrent Calcium Channel Blocker on Antiplatelet Efficacy of Clopidogrel Therapy: A Systematic Review.
The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients.
New P2Y12 antagonists.
Enhanced Platelet Response to Clopidogrel in Abcc3-deficient Mice Due to Its Increased Bioactivation.